Literature DB >> 18722261

Balancing on a knife's edge: evidence-based medicine and the marketing of health technology.

Søren M Bentzen1, Todd H Wasserman.   

Abstract

Mesh：

Year:  2008        PMID： 18722261     DOI： 10.1016/j.ijrobp.2008.05.044

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Accuracy of marketing claims by providers of stereotactic radiation therapy.

Authors:  Amol K Narang; Edwin Lam; Martin A Makary; Theodore L Deweese; Timothy M Pawlik; Peter J Pronovost; Joseph M Herman
Journal:  J Oncol Pract       Date:  2013-01       Impact factor: 3.840

2.  Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.

Authors:  James B Yu; Laura D Cramer; Jeph Herrin; Pamela R Soulos; Arnold L Potosky; Cary P Gross
Journal:  J Clin Oncol       Date:  2014-03-10       Impact factor: 44.544

3.  The road not taken and choices in radiation oncology.

Authors:  C Norman Coleman; Eli Glatstein
Journal:  Oncologist       Date:  2010

Review 4.  Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices.

Authors:  Danielle S Bitterman; Daniel N Cagney; Lisa L Singer; Paul L Nguyen; Paul J Catalano; Raymond H Mak
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.